Pepcid and Firdapse drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pepcid (famotidine) and Firdapse (amifampridine). Common drug interactions include dizziness among females and intestinal obstruction among males.

The phase IV clinical study analyzes what interactions people have when they take Pepcid and Firdapse. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.

What is Firdapse?

Firdapse has active ingredients of amifampridine. eHealthMe is studying from 2,112 Firdapse users. Check the latest studies of Firdapse.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

45 people who take Pepcid and Firdapse together, and have interactions are studied.

Pepcid and Firdapse drug interactions.

What are the common drug interactions of Pepcid and Firdapse, by gender? *:

female:

  1. Dizziness
  2. Sudden death
  3. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  4. Haematuria (presence of blood in urine)
  5. Haemoglobin decreased
  6. Adjustment disorder with depressed mood
  7. Chest discomfort
  8. Depressed mood
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Emotional distress

male:

  1. Intestinal obstruction
  2. Road traffic accident
  3. Dizziness
  4. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  5. Hyporeflexia (a condition of below normal or absent reflexes)
  6. Myasthenic syndrome (a group of conditions characterized by muscle weakness (myasthenia) that worsens with physical exertion)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Sinus congestion (blockage of sinus)
  9. Weight decreased
  10. Bacteraemia (presence of bacteria in the blood)

What are the common drug interactions of Pepcid and Firdapse, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Hypophagia (reduced food intake)
  2. Influenza
  3. Nausea (feeling of having an urge to vomit)
  4. Therapeutic response unexpected
  5. Vomiting

30-39:

  1. Dizziness
  2. Drug ineffective
  3. Headache (pain in head)
  4. Cystitis (inflammation of the wall of the bladder)
  5. Gastritis (inflammation of stomach)
  6. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  7. Hyperbilirubinaemia (excess of bilirubin in the blood)
  8. Hypertransaminasaemia
  9. Iron deficiency anaemia
  10. Rectal haemorrhage (bleeding from anus)

40-49:

n/a

50-59:

  1. Emotional distress
  2. Exercise tolerance decreased
  3. Eyelid disorder
  4. Gait disturbance
  5. Mobility decreased (ability to move is reduced)
  6. Muscle tightness
  7. Muscular weakness (muscle weakness)
  8. Nervousness
  9. Quality of life decreased
  10. Respiratory muscle weakness

60+:

  1. Septic shock (shock due to blood infection)
  2. Asthenia (weakness)
  3. Proteus infection (proteus can cause urinary tract infections)
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Urinary tract infection
  6. Anaemia (lack of blood)
  7. Performance status decreased
  8. Klebsiella sepsis (klebsiella causes a potentially fatal whole-body inflammation)
  9. Nephropathy toxic (damage to kidney due to toxins)
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

What are the existing conditions these people have? *

  1. Lambert-Eaton Syndrome (this means your immune system mistakenly targets healthy cells and tissues in the body): 44 people, 97.78%
  2. Thyroid Cancer: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid and Firdapse?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pepcid and Firdapse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pepcid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Firdapse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pepcid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Firdapse and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on famotidine and amifampridine (the active ingredients of Pepcid and Firdapse, respectively), and Pepcid and Firdapse (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: